why choose us

First received: January 26, 2023

Clinical Trial: A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine

Study Status: Completed

Recruit Status: RECRUITING

Condition: Episodic Migraine

Study Type: INTERVENTIONAL


Official Title: A Phase 3, Multicenter, 12-Week, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Atogepant for the Preventive Treatment of Episodic Migraine in Pediatric Subjects 6-17 Ye

Brief Summary: A migraine is a moderate to severe headache on one side of the head.A migraine attack is a headache that may be accompanied by throbbing, nausea, vomiting, sensitivity to light and sound, or other symptoms.A number of treatments are available for adults with migraine but there are limited approved treatments available for pediatric participants.The main goal of the study is to evaluate the safety and efficacy (how well treatment works) of a low-dose and high-dose of atogepant in pediatric participants between the…

Read more